Forest Laboratories Inc. said it received a subpoena for documents related to the high blood pressure drugs Benicar, Benicar HCT and Azor.
The New York drugmaker said Monday that the subpoena came from the Office of the U.S. Attorney for the District of Massachusetts, and was dated April 20. Forest marketed Benicar from 2002 through 2008 under a partnership with Japanese drugmaker Daiichi Sankyo. Forest said it intends to cooperate in responding to the subpoena.
Shares of Forest Laboratories lost 6 cents to $34.20 in afternoon trading.